822O Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial)

Autor: Garciaz, S., Champiat, S., Peterlin, P., Lemmens, K., de Gassart, A., Brune, P., Valentin, E., Leparquier, C., Iche, M., Olive, D., Vey, N., Frohna, P.A.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S543-S543
Databáze: ScienceDirect